The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.

ASEAN: EMERGING HOTSPOT FOR
BIG PHARMAS
ASEAN is growing, and growing with
it is the region’s pharma sector.
With growth in developed markets
flattening, pharma industry
is betting on lucrative ASEAN
markets for profits. Think of Asia’s
emerging markets and the instant
names that appear are India and China.
Undoubtedly, these are huge markets
for the industry. But apart from these
main markets, ASEAN’s emerging markets,
with an annual growth rate of 11 per cent and
huge untapped potential, provide a massive
opportunity for big pharma to expand and grow in
this region.
29

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by MMA Media, 2018-06-28 05:39:49

BioSpectrum Asia July 2018

ASEAN: EMERGING HOTSPOT FOR
BIG PHARMAS
ASEAN is growing, and growing with
it is the region’s pharma sector.
With growth in developed markets
flattening, pharma industry
is betting on lucrative ASEAN
markets for profits. Think of Asia’s
emerging markets and the instant
names that appear are India and China.
Undoubtedly, these are huge markets
for the industry. But apart from these
main markets, ASEAN’s emerging markets,
with an annual growth rate of 11 per cent and
huge untapped potential, provide a massive
opportunity for big pharma to expand and grow in
this region.
29

Keywords: ASEAN ,Malaysia,Thailand,China,singapore,japan,maldives,taiwan,europe,asia

Click to View FlipBook Version